CA2014659A1 - Composes pharmaceutiques pour le soulagement de la dysmenorrhee et (ou) du syndrome premenstruel et procede - Google Patents

Composes pharmaceutiques pour le soulagement de la dysmenorrhee et (ou) du syndrome premenstruel et procede

Info

Publication number: CA2014659A1
Authority: CA; Canada
Prior art keywords: dysmenorrhea; relief; premenstrual syndrome; pharmaceutical compositions; hydrochlorothiazide
Prior art date: 1989-12-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2014659A

Other languages

English (en)

Other versions

CA2014659C (fr

Inventor

Howard Jones

Alison B. Lukacsko

Joseph Migliardi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Squibb Co

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-15

Filing date

1990-04-17

Publication date

1991-06-15

1989-12-15 Priority claimed from US07/452,022 external-priority patent/US5037823A/en

1990-04-17 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1991-06-15 Publication of CA2014659A1 publication Critical patent/CA2014659A1/fr

1996-01-09 Application granted granted Critical

1996-01-09 Publication of CA2014659C publication Critical patent/CA2014659C/fr

2010-04-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

208000005171 Dysmenorrhea Diseases 0.000 title abstract 3
206010013935 Dysmenorrhoea Diseases 0.000 title abstract 3
206010036618 Premenstrual syndrome Diseases 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 abstract 2
HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 2
229960002003 hydrochlorothiazide Drugs 0.000 abstract 2
229960001680 ibuprofen Drugs 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000002831 pharmacologic agent Substances 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CA002014659A 1989-12-15 1990-04-17 Composes pharmaceutiques pour le soulagement de la dysmenorrhee et (ou) du syndrome premenstruel et procede Expired - Fee Related CA2014659C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US452,022		1989-12-15
US07/452,022 US5037823A (en)	1986-09-15	1989-12-15	Pharmaceutical compositions for relief of dysmenorrhea and/or premenstrual syndrome and process

Publications (2)

Publication Number	Publication Date
CA2014659A1 true CA2014659A1 (fr)	1991-06-15
CA2014659C CA2014659C (fr)	1996-01-09

Family

ID=23794697

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002014659A Expired - Fee Related CA2014659C (fr)	1989-12-15	1990-04-17	Composes pharmaceutiques pour le soulagement de la dysmenorrhee et (ou) du syndrome premenstruel et procede

Country Status (1)

Country	Link
CA (1)	CA2014659C (fr)

1990
- 1990-04-17 CA CA002014659A patent/CA2014659C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2014659C (fr)	1996-01-09

Similar Documents

Publication	Publication Date	Title
CA2258920A1 (fr)	1997-12-31	Acide hyaluronique autoreticule et compositions pharmaceutiques associees pour le traitement des arthropathies
CA2004239A1 (fr)	1990-06-01	Utilisation de l'acetyl-d-carnitine dans le traitement therapeutique du glaucome et composes pharmaceutiques utiles dans un tel traitement
CA2258095A1 (fr)	1998-08-13	Compositions contenant de la tetrahydrolipstatine
GEP20033131B (en)	2003-12-25	Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
CA2319201A1 (fr)	2000-06-08	Compositions a base de celecoxib
CA2086343A1 (fr)	1993-07-01	Composition thyroactive a liberation prolongee
CA2203033A1 (fr)	1996-05-02	Composes et compositions pour l'administration d'agents actifs
CA2009890A1 (fr)	1991-08-13	Acide valproique
CA2419993A1 (fr)	2002-03-07	Preparation de compositions pharmaceutiques a utiliser avec des formulations gelatineuses molles
CA2091360A1 (fr)	1992-03-11	Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
CA2065285A1 (fr)	1992-02-09	Compositions antimalariennes
CA2079342A1 (fr)	1991-09-29	Composes pharmaceutiques multifonctionnels, leur methode de fabrication et leurs utilisations
AU764280C (en)	2004-06-24	Process for the preparation of pellets with a content of up to 90 wt. per cent of a pharmaceutical active ingredient
CA2152615A1 (fr)	1994-07-07	Compositions pharmaceutiques a base d'atovaquone
IL102814A0 (en)	1993-01-31	Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them
CA2285242A1 (fr)	1998-10-08	Melange d'acides gras primaires obtenus a partir de la cire de canne a sucre
CA2039053A1 (fr)	1991-09-28	Materiau d'absorbtion du pyrogene
CA2238389A1 (fr)	1997-05-29	Nouveaux derives geranyl-geranyle, procede pour les preparer et compositions pharmaceutiques les contenant
CA2052901A1 (fr)	1992-10-06	Formulations a action pharmacologique accrue
CA2135614A1 (fr)	1993-11-25	Utilisation de l'urodilatine pour les affections pulmonaires et bronchiques
AU566228B2 (en)	1987-10-15	Compressed hydroxybutryic acid polymer retarded release vehicle
CA2078869A1 (fr)	1991-09-24	Compositions pharmaceutiques contenant de l'ipriflavone, leur procede de preparation et leur emploi therapeutique relatif
CA2344686A1 (fr)	2000-04-27	Composition a degre eleve de purete renfermant (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
CA2047802A1 (fr)	1992-01-26	Compositions pharmaceutiques
JPS5781409A (en)	1982-05-21	External plaster

Legal Events

Date	Code	Title	Description
1991-01-28	EEER	Examination request
2004-04-19	MKLA	Lapsed